Please login to the form below

Not currently logged in
Email:
Password:

More M&A activity in China

China-based drug developer Simcere Pharmaceutical has said it will buy a 51 per cent stake in Bada Pharmaceutical for about CNY 111m (USD 14.8m) in cash to strengthen its position in the stroke management market.

China-based drug developer Simcere Pharmaceutical has said it will buy a 51 per cent stake in Bada Pharmaceutical for about CNY 111m (USD 14.8m) in cash to strengthen its position in the stroke management market.

Simcere takes the lead in the whole injectable edaravone market in China, with a neuroprotective stroke management medication with a name of Bicun. As the first of its kind in the Chinese market, Bicun occupied a top market share and strong growth rate. The total sales of Bicun increased 209.5 per cent from 2004 to 2006, and sales reached CNY 110m in Q2 FY07, an increase of 134 per cent on the same period of FY06.

The acquisition of Boda is the first one of Simcere after it launched IPO in April 2007. Simcere acquired anti-cancer drug manufacturer Endu in 2006.

Simcere expects to expand its first-to-market pipeline and explore new drug business through more strategic acquisitions.

Established in 1995, Simcere has evolved from a distributor of pharmaceutical products into a leading manufacturer and supplier of drugs in the rapidly growing Chinese pharmaceutical market. It has three Good Manufacturing Practices (GMP)-certified manufacturing bases, two nationwide sales and marketing subsidiaries, one research and development centre and employs over 1,800 people.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics